| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Dec 31, 2023 | Option Exercise | $7.96 | 4,700 | 37,412 | 962,790 | Jan 02, 2024, 07:41 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Sep 30, 2023 | Option Exercise | $6.47 | 4,700 | 30,409 | 967,490 | Oct 03, 2023, 04:59 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Jun 30, 2023 | Option Exercise | $5.90 | 4,290 | 25,311 | 972,190 | Jul 03, 2023, 05:31 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Mar 31, 2023 | Option Exercise | $3.90 | 4,825 | 18,818 | 976,480 | Apr 04, 2023, 05:02 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Sep 30, 2022 | Option Exercise | $4.25 | 7,154 | 30,405 | 906,602 | Jan 13, 2023, 05:46 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Dec 31, 2022 | Option Exercise | $3.10 | 2,497 | 7,741 | 911,259 | Jan 04, 2023, 07:20 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Sep 30, 2022 | Sale | $4.07 | 2,328 | 9,469 | 911,428 | Oct 04, 2022, 05:04 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Oct 03, 2022 | Sale | $3.95 | 2,853 | 11,270 | 908,575 | Oct 04, 2022, 05:04 PM | |
| CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | Jan 28, 2022 | Buy | $9.05 | 27,500 | 248,754 | 27,500 | Feb 01, 2022, 08:15 PM |
Menu